# Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease 

Source: https://onco.cc/trials/nct06191744/  
OnCo record `nct06191744` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Epcoritamab, Prednisone, Rituximab in follicular lymphoma, run by Genmab, active and no longer recruiting.

## Summary

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma is a phase 3 interventional study registered as NCT06191744 by Genmab, with 1095 participants enrolled, started 2024-02-05 and due to reach its primary completion in 2037-11. Interventions recorded: Epcoritamab, Prednisone, Rituximab, Lenalidomide, Doxorubicin. Conditions listed: Follicular Lymphoma (FL). No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT06191744
- Phase: 3
- Setting: A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) Compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma (EPCORE™FL-2)
- Sponsor: Genmab
- Enrolled: 1095

## Sources

- ClinicalTrials.gov NCT06191744: https://clinicaltrials.gov/study/NCT06191744

## Connected records

- cancers: [Follicular lymphoma](https://onco.cc/cancers/follicular-lymphoma/)
- drugs: [Doxorubicin](https://onco.cc/drugs/doxorubicin/), [Epcoritamab](https://onco.cc/drugs/epcoritamab/), [Lenalidomide](https://onco.cc/drugs/lenalidomide/), [Prednisone](https://onco.cc/drugs/prednisone/), [Rituximab](https://onco.cc/drugs/rituximab/), [Vincristine](https://onco.cc/drugs/vincristine/)
- companies: [Genmab](https://onco.cc/companies/genmab/)

---
JSON: https://onco.cc/api/v1/entities/nct06191744.json